Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Chhabra

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Computational Intelligence and Neuroscience|July 21, 2022
Improved Fitness-Dependent Optimizer for Solving Economic Load Dispatch ProblemBarzan Hussein Tahir, Tarik A Rashid, Hafiz Tayyab Rauf, et al.
Managed Care (Langhorne, Pa.)|October 13, 2018
Real-World Analysis of Dispensed International Units of Coagulation Factor VIII and Resultant Expenditures for Hemophilia A Patients: A Comparison Between Standard Half-Life and Extended Half-Life ProductsAmit Chhabra, Patrick F Fogarty, Bartholomew J Tortella, et al.
Scientific Reports|December 20, 2023
A novel hybrid model integrating MFCC and acoustic parameters for voice disorder detectionVyom Verma, Anish Benjwal, Amit Chhabra, et al.
BMC Health Services Research|November 20, 2024
Distribution and predictors of haemophilia-related costs in the United Kingdom: analysis of the CHESS I and CHESS II burden of illness studiesIone Woollacott, Amit Chhabra, Tom Burke, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 10, 2020
Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and BAmit Chhabra, Dean Spurden, Patrick F Fogarty, et al.
Molecular Therapy. Methods & Clinical Development|July 18, 2024
Global seroprevalence of neutralizing antibodies against adeno-associated virus serotypes used for human gene therapiesAmit Chhabra, George Bashirians, Christos J Petropoulos, et al.
Scientific Reports|February 19, 2026
Improving predictive reliability and automation of smart grids using the StarNet ensemble modelAmit Chhabra, Sunil K Singh, Sudhakar Kumar, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|October 4, 2023
Nonacog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients with Moderately Severe or Severe Hemophilia B in IndiaNirmalkumar Choraria, Savita Rangarajan, M Joseph John, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|December 5, 2022
Moroctocog Alfa (AF-CC) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients with Hemophilia A in IndiaNirmalkumar Choraria, Savita Rangarajan, M Joseph John, et al.
The New England Journal of Medicine|April 16, 2025
Fidanacogene Elaparvovec for Hemophilia B - A Multiyear Follow-up StudyJohn E J Rasko, Benjamin J Samelson-Jones, Lindsey A George, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Computational Intelligence and Neuroscience|July 21, 2022
Improved Fitness-Dependent Optimizer for Solving Economic Load Dispatch ProblemBarzan Hussein Tahir, Tarik A Rashid, Hafiz Tayyab Rauf, et al.
Managed Care (Langhorne, Pa.)|October 13, 2018
Real-World Analysis of Dispensed International Units of Coagulation Factor VIII and Resultant Expenditures for Hemophilia A Patients: A Comparison Between Standard Half-Life and Extended Half-Life ProductsAmit Chhabra, Patrick F Fogarty, Bartholomew J Tortella, et al.
Scientific Reports|December 20, 2023
A novel hybrid model integrating MFCC and acoustic parameters for voice disorder detectionVyom Verma, Anish Benjwal, Amit Chhabra, et al.
BMC Health Services Research|November 20, 2024
Distribution and predictors of haemophilia-related costs in the United Kingdom: analysis of the CHESS I and CHESS II burden of illness studiesIone Woollacott, Amit Chhabra, Tom Burke, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 10, 2020
Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and BAmit Chhabra, Dean Spurden, Patrick F Fogarty, et al.
Molecular Therapy. Methods & Clinical Development|July 18, 2024
Global seroprevalence of neutralizing antibodies against adeno-associated virus serotypes used for human gene therapiesAmit Chhabra, George Bashirians, Christos J Petropoulos, et al.
Scientific Reports|February 19, 2026
Improving predictive reliability and automation of smart grids using the StarNet ensemble modelAmit Chhabra, Sunil K Singh, Sudhakar Kumar, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|October 4, 2023
Nonacog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients with Moderately Severe or Severe Hemophilia B in IndiaNirmalkumar Choraria, Savita Rangarajan, M Joseph John, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|December 5, 2022
Moroctocog Alfa (AF-CC) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients with Hemophilia A in IndiaNirmalkumar Choraria, Savita Rangarajan, M Joseph John, et al.
The New England Journal of Medicine|April 16, 2025
Fidanacogene Elaparvovec for Hemophilia B - A Multiyear Follow-up StudyJohn E J Rasko, Benjamin J Samelson-Jones, Lindsey A George, et al.
Pageof 4